Mecasermin (INN) (brand name Increlex), also known as recombinant human insulin-like growth factor-1 (rhIGF-1), is a recombinant form of human insulin-like growth factor 1 (IGF-I) which is used in the long-term treatment of growth failure and short stature in children with severe primary IGF-I deficiency, for instance due to growth hormone deficiency or Laron syndrome (growth hormone insensitivity).<\/p>\n
If Increlex (mecasermin) injection<\/strong> are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/p>\n Note:<\/strong> NEWS \/ UPDATES<\/strong><\/p>\n INCRELEX\u00ae (mecasermin [rDNA origin] injection) is indicated for the treatment of growth failure in children with severe primary IGF-1 deficiency or with growth hormone (GH) gene deletion who have developed neutralizing antibodies to GH.\u00a0Increlex’s active principle (IGF-1) for the treatment of Severe Primary IGF-1 Deficiency (Primary IGFD) is manufactured by Lonza Biologics Inc. at its Hopkinton, MA facility. Ipsen and Lonza will continue to work with FDA in the supply of US patients with this important drug.<\/p>\n Source Details:\u00a0Patient Information<\/strong><\/a><\/p>\n If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import Increlex (mecasermin) injection\u201d <\/strong> based on the information you provide.<\/p>\n
\nWe are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.<\/p>\n\n
Increlex (mecasermin) injection<\/h2>\n
\n\n
\n Brand Name:<\/strong><\/td>\n Increlex<\/td>\n<\/tr>\n \n Generic Name:<\/strong><\/td>\n mecasermin<\/td>\n<\/tr>\n \n Strength:<\/strong><\/td>\n \u2022 INCRELEX\u00ae is a sterile solution supplied in a multiple dose glass vial\u00a0 a concentration of 10 mg per mL (40 mg per vial).<\/td>\n<\/tr>\n \n Manufacturer:<\/strong><\/td>\n \u00a0Ipsen<\/td>\n<\/tr>\n \n Approved By:<\/strong><\/td>\n EMA, USFDA<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n Access the best support services globally<\/h4>\n